ImmunovantInc Historical Valuation

IMVT Stock  USD 28.61  0.13  0.45%   
Some fundamental drivers such as market cap or ImmunovantInc enterprice value can be analyzed from historical perspective to project value of the company into the future. Some investors analyze ImmunovantInc valuation indicators such as Enterprise Value of 185.8 K to time the market or to short-sell their positions based on the trend in valuation ratios. It is a perfect tool to project the direction of ImmunovantInc's future value.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in ImmunovantInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real.
For more information on how to buy ImmunovantInc Stock please use our How to Invest in ImmunovantInc guide.

About ImmunovantInc Valuation Data Analysis

Valuation is the financial process of determining what ImmunovantInc is worth. ImmunovantInc valuation ratios put that insight into the context of a company's share price, where they serve as useful tools for evaluating and utilizing investment potential. ImmunovantInc valuation ratios help investors to determine whether ImmunovantInc Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ImmunovantInc with respect to the benefits of owning ImmunovantInc security.

ImmunovantInc Valuation Data Chart

ImmunovantInc valuation ratios help to determine how cheap or expensive it is, compared to its peers or based on some benchmark measure of value for a given date. A typical valuation ratio shows the difference between the cost of ImmunovantInc equity instrument and the benefits of owning shares of ImmunovantInc.
Market Cap is likely to drop to about 209.6 K in 2024. Enterprise Value is likely to drop to about 185.8 K in 2024

Enterprise Value

Enterprise Value (or EV) is usually referred to as ImmunovantInc theoretical takeover price. In the event of an acquisition, an acquirer would have to take on ImmunovantInc debt, but would also pocket its cash. Enterprise Value is more accurate representation of ImmunovantInc value than its market capitalization because it takes into account all of ImmunovantInc existing debt. A measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization that includes the market capitalization, plus total debt, minority interest and preferred shares, minus total cash and cash equivalents.

ImmunovantInc Investors Sentiment

The influence of ImmunovantInc's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in ImmunovantInc. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to ImmunovantInc's public news can be used to forecast risks associated with an investment in ImmunovantInc. The trend in average sentiment can be used to explain how an investor holding ImmunovantInc can time the market purely based on public headlines and social activities around ImmunovantInc. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
ImmunovantInc's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for ImmunovantInc's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average ImmunovantInc's news discussions. The higher the estimated score, the more favorable is the investor's outlook on ImmunovantInc.

ImmunovantInc Implied Volatility

    
  78.88  
ImmunovantInc's implied volatility exposes the market's sentiment of ImmunovantInc stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if ImmunovantInc's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that ImmunovantInc stock will not fluctuate a lot when ImmunovantInc's options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards ImmunovantInc in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, ImmunovantInc's short interest history, or implied volatility extrapolated from ImmunovantInc options trading.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether ImmunovantInc is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if ImmunovantInc Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Immunovantinc Stock. Highlighted below are key reports to facilitate an investment decision about Immunovantinc Stock:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in ImmunovantInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real.
For more information on how to buy ImmunovantInc Stock please use our How to Invest in ImmunovantInc guide.
You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.

Complementary Tools for ImmunovantInc Stock analysis

When running ImmunovantInc's price analysis, check to measure ImmunovantInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ImmunovantInc is operating at the current time. Most of ImmunovantInc's value examination focuses on studying past and present price action to predict the probability of ImmunovantInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ImmunovantInc's price. Additionally, you may evaluate how the addition of ImmunovantInc to your portfolios can decrease your overall portfolio volatility.
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Is ImmunovantInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ImmunovantInc. If investors know ImmunovantInc will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ImmunovantInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.81)
Return On Assets
(0.27)
Return On Equity
(0.45)
The market value of ImmunovantInc is measured differently than its book value, which is the value of ImmunovantInc that is recorded on the company's balance sheet. Investors also form their own opinion of ImmunovantInc's value that differs from its market value or its book value, called intrinsic value, which is ImmunovantInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ImmunovantInc's market value can be influenced by many factors that don't directly affect ImmunovantInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ImmunovantInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if ImmunovantInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ImmunovantInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.